Genelux (GNLX) Market Capitalization (2023 - 2026)
Genelux (GNLX) posted Market Capitalization of $108.5 million for Q1 2026, down 34.74% on a QoQ basis from $166.3 million in Q4 2025, and up 6.51% year-over-year from $101.9 million in Q1 2025.
Analysis
Genelux (GNLX) Market Capitalization (2023 - 2026) Analysis & Trends
Genelux has reported Market Capitalization for 4 years, with the latest figure at $108.5 million in Q1 2026.
- On a quarterly basis, Market Capitalization rose 6.51% year-over-year to $108.5 million in Q1 2026; TTM through Mar 2026 was $108.5 million, a 6.51% increase from a year earlier, with the FY2025 full-year figure at $166.3 million, up 102.89% from the prior year.
- Market Capitalization was $108.5 million for Q1 2026 at Genelux, down from $166.3 million in the prior quarter.
- The five-year high for Market Capitalization was $846.0 million in Q2 2023, with the low at $67.3 million in Q2 2024.
- Average Market Capitalization over 4 years is $266.7 million, with a median of $159.8 million recorded in 2025.
- The sharpest annual moves came in 2024 and 2025: Market Capitalization slumped 92.04% in 2024, then jumped 102.89% in 2025.
- Over 4 years, Market Capitalization stood at $375.3 million in 2023, then sank by 78.16% to $82.0 million in 2024, then jumped by 102.89% to $166.3 million in 2025, then slumped by 34.74% to $108.5 million in 2026.
- The last three Market Capitalization figures came in at $108.5 million (Q1 2026), $166.3 million (Q4 2025), and $159.8 million (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn |
| 10 | Genelux | 108.17 Mn | 108.17 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 108.51 Mn |
| Dec 31, 2025 | 166.29 Mn |
| Sep 30, 2025 | 159.80 Mn |
| Jun 30, 2025 | 108.37 Mn |
| Mar 31, 2025 | 101.88 Mn |
| Dec 31, 2024 | 81.96 Mn |
| Sep 30, 2024 | 81.86 Mn |
| Jun 30, 2024 | 67.30 Mn |
| Mar 31, 2024 | 173.59 Mn |
| Dec 31, 2023 | 375.31 Mn |
| Sep 30, 2023 | 652.85 Mn |
| Jun 30, 2023 | 845.99 Mn |
| Mar 31, 2023 | 543.03 Mn |